Dr Sheeba Irshad is a Breast Cancer Medical Oncologist at Guy’s & St Thomas’ NHS Trust and a Senior Clinical Lecturer at King’s College London. She is also a Cancer Research UK Clinician Scientist.
Following her return as a visiting scientist at The Sidney Kimmel Comprehensive Cancer Center at John’s Hopkins University, Baltimore; Dr Irshad was appointed as a Clinical Deputy Head of King’s College London Breast Cancer Now Research Unit Programme in 2018.
She specialises in researching hard to treat breast cancers, such as those that are resistant to chemotherapy. Her research is focused on understanding the tumour-immune cell cross talk in chemotherapy resistant cancers with particular emphasis on understanding mechanisms that underpin how cells from the immune system move within tumours. The goal is to find effective immunotherapy treatments for patients.
She is also the translational lead and coordinating investigator for a clinical trial platform to explore the potential interactions between DNA damage response inhibitors and immunotherapy in high-risk Triple Negative Breast Cancers.